
Ali M. Imam
Examiner (ID: 14135)
| Most Active Art Unit | 3737 |
| Art Unit(s) | 3737 |
| Total Applications | 818 |
| Issued Applications | 688 |
| Pending Applications | 87 |
| Abandoned Applications | 43 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16791767
[patent_doc_number] => 20210121584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => TRIFUNCTIONAL CONSTRUCTS WITH TUNABLE PHARMACOKINETICS USEFUL IN IMAGING AND ANTI-TUMOR THERAPIES
[patent_app_type] => utility
[patent_app_number] => 17/132552
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17132552
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/132552 | TRIFUNCTIONAL CONSTRUCTS WITH TUNABLE PHARMACOKINETICS USEFUL IN IMAGING AND ANTI-TUMOR THERAPIES | Dec 22, 2020 | Abandoned |
Array
(
[id] => 16726434
[patent_doc_number] => 20210093581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 17/119873
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119873
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/119873 | Use of cannabinoids in the treatment of epilepsy | Dec 10, 2020 | Issued |
Array
(
[id] => 16885295
[patent_doc_number] => 20210171490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => RED-SHIFTED FLUOROPHORES
[patent_app_type] => utility
[patent_app_number] => 17/116987
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 347
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116987 | Red-shifted fluorophores | Dec 8, 2020 | Issued |
Array
(
[id] => 16932352
[patent_doc_number] => 20210198241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS
[patent_app_type] => utility
[patent_app_number] => 17/112156
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112156
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112156 | Substituted tetrahydrofurans as modulators of sodium channels | Dec 3, 2020 | Issued |
Array
(
[id] => 18537408
[patent_doc_number] => 20230242500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHOD FOR MANUFACTURING (2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)METHANOL
[patent_app_type] => utility
[patent_app_number] => 17/782075
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782075
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782075 | Method for manufacturing (2,2-dimethyl-1,3-dioxolan-4-yl)methanol | Nov 30, 2020 | Issued |
Array
(
[id] => 16991710
[patent_doc_number] => 20210230130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => NON-FULLERENE ACCEPTOR COMPOUND CONTAINING BENZOSELENADIAZOLE AND ORGANIC OPTOELECTRONIC DEVICE INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/105673
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105673
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105673 | Non-fullerene acceptor compound containing benzoselenadiazole and organic optoelectronic device including the same | Nov 26, 2020 | Issued |
Array
(
[id] => 19731072
[patent_doc_number] => 12209062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Nitrile oxide compound
[patent_app_type] => utility
[patent_app_number] => 17/104957
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16446
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104957
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104957 | Nitrile oxide compound | Nov 24, 2020 | Issued |
Array
(
[id] => 18226959
[patent_doc_number] => 20230065953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES
[patent_app_type] => utility
[patent_app_number] => 17/779703
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779703
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779703 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Nov 23, 2020 | Abandoned |
Array
(
[id] => 16711815
[patent_doc_number] => 20210078962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 17/101239
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101239
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/101239 | Prodrugs of riluzole and their method of use | Nov 22, 2020 | Issued |
Array
(
[id] => 20452999
[patent_doc_number] => 12516049
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Sulfonylurea ring substituted monocyclic b-lactam antibiotics
[patent_app_type] => utility
[patent_app_number] => 17/777704
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7485
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777704
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/777704 | Sulfonylurea ring substituted monocyclic b-lactam antibiotics | Nov 19, 2020 | Issued |
Array
(
[id] => 16900654
[patent_doc_number] => 20210179570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/100107
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67084
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100107
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/100107 | Processes and intermediates for preparing MCL1 inhibitors | Nov 19, 2020 | Issued |
Array
(
[id] => 18269740
[patent_doc_number] => 20230090982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => DRUG FOR TREATING CORONAVIRAL AND RETROVIRAL INFECTIONS AND HEPATITIS C
[patent_app_type] => utility
[patent_app_number] => 17/798282
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798282 | DRUG FOR TREATING CORONAVIRAL AND RETROVIRAL INFECTIONS AND HEPATITIS C | Nov 18, 2020 | Abandoned |
Array
(
[id] => 16657276
[patent_doc_number] => 20210053912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/091222
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091222
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/091222 | Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof | Nov 5, 2020 | Issued |
Array
(
[id] => 18169801
[patent_doc_number] => 20230036412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => PEGYLATED ICD INDUCER-IDO INHIBITOR NANOCONJUGATE, AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/785162
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3129
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/785162 | PEGylated ICD inducer-IDO inhibitor nanoconjugate, and preparation method and use thereof | Nov 1, 2020 | Issued |
Array
(
[id] => 17096861
[patent_doc_number] => 20210284652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => ALDOSE REDUCTASE INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/086699
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086699
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/086699 | Aldose reductase inhibitors and methods of use thereof | Nov 1, 2020 | Issued |
Array
(
[id] => 16762287
[patent_doc_number] => 20210107868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
[patent_app_type] => utility
[patent_app_number] => 17/081162
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/081162 | DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS | Oct 26, 2020 | Abandoned |
Array
(
[id] => 18643246
[patent_doc_number] => 11767306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Methods for converting CBD to tetrahydrocannabinols
[patent_app_type] => utility
[patent_app_number] => 17/076052
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4869
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/076052 | Methods for converting CBD to tetrahydrocannabinols | Oct 20, 2020 | Issued |
Array
(
[id] => 16776624
[patent_doc_number] => 20210113701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => BRUSH PRODRUGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/072015
[patent_app_country] => US
[patent_app_date] => 2020-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072015
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/072015 | Brush prodrugs and uses thereof | Oct 14, 2020 | Issued |
| 17/067891 | HEXASUBSTITUTED RADIALENE ANIONS FOR SOLUBILITY ENHANCEMENT IN AQUEOUS ORGANIC CATHOLYTES | Oct 11, 2020 | Abandoned |
Array
(
[id] => 16762286
[patent_doc_number] => 20210107867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/063497
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063497 | Ultra short acting anti-arrhythmic agents | Oct 4, 2020 | Issued |